SMO Clinical Researchsp. z o.o. in liquidation
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2018-08-23
Share capital
9,900.00 PLN
Registered address
ul. Adolfa Pawińskiego 5, 02-106 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2020 – the filing deadline has passed.
- 2020not filed
- 201930/06/2020
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2019.
Industry · Other research and experimental development on natural sciences and engineering1,319 / 1,564
Top 84%
Voivodeship · Mazowieckie123,531 / 142,058
Top 87%
Country · Poland439,238 / 495,976
Top 89%
Results vs industry
Revenue
This companyUSD 2.47kMedianUSD 73.59kAverageUSD 3.23m
Net profit
This companyUSD -1.21kMedianUSD 68.18AverageUSD 82.13k
Operating costs
This companyUSD 3.38kMedianUSD 76.19kAverageUSD 3.05m
Assets
This companyUSD 1.37kMedianUSD 120.44kAverageUSD 3.90m
Industry
- Publishing of books, periodicals and other publishing activities, excluding software (58.1)
Authorized Representatives
Marta Zakrzewska – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Marian Miazgaage 64 | 18 | $486.22 | 18.1818% |
Others | 81 | $2,188.01 | 81.8182% |
Beneficial owners
No beneficial owners recorded for the company SMO Clinical Research.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 24, 2021 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| HTPsp. z o.o. | $13,728.34 | htp7.pl | ||
| Renewablepowersp. z o.o. | $11,568.22 | renewablepower.pl | ||
| Microanalysissp. z o.o. | $1,425.98 | microanalysis.pl | ||
| DEEP Technologysp. z o.o. | $1,202.71 | deeptechnology.ai | ||
| Microbiota Medsp. z o.o. | $916.10 | microbiota-med.com | ||
| Nevomo Iotsp. z o.o. | $502.62 | nevomo.tech | ||
| Grera Connectsp. z o.o. | $39.66 | meshr.io | ||
| ORCA ComputingBranch (foreign co.) | $0.32 | orcacomputing.com | ||
| Iqcredosp. z o.o. | $0.20 | iqcredo.com | ||
| Omega Innovations sp. z o.o.sp. k. | $0.10 | omegainnovations.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-27 | Business resumed | |
| 2021-03-10 | Name change (Smo Clinical Research → Smo Clinical Research Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2021-01-20 | Liquidation opened | |
| 2020-01-01 | Business suspended | |
| 2018-08-23 | Entered in the register |
FAQ
The main business activity of SMO Clinical Research focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on August 23, 2018.
The headquarters is located at: ul. Adolfa Pawińskiego 5, 02-106 Warszawa.
The share capital of the company is PLN 9,900 (approx. $2,674).
The latest available financial statement covers the period from August 23, 2018 to December 31, 2019.
In 2019, the company generated total revenue of $2,474.
No, in 2019 the company was not profitable, reporting a net loss of $1,208.
The largest operating cost category falls under other operating costs. This category amounted to $104 in 2019, representing 3% of all operating expenses.
Last updated: 2026-04-08